CEMIP and prostate cancer: It has been claimed that MCT1-mediated elevation of lactate can stimulate hyaluronan (HA)-binding protein KIAA1199 signaling via enhancing HIF1α lactylation, thereby triggering the pro-angiogenic role of KIAA1199 in prostate cancer and laying the groundwork for the exploration of new therapeutic targets (67).